WHO ICTRP trial

Muscle wasting in chronic obstructive pulmonary disease (COPD): the role of…

ISRCTN22764439 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN22764439
Public title Muscle wasting in chronic obstructive pulmonary disease (COPD): the role of resistance training and protein supplementation
Scientific title Molecular approaches to reversing skeletal muscle wasting in chronic obstructive pulmonary disease (COPD): the role of resistance training and protein supplementation - a double-blind randomised placebo-controlled trial
Primary sponsor University Hospitals of Leicester NHS Trust (UK)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Countries United Kingdom
Conditions Chronic obstructive pulmonary disease (COPD) Respiratory Other chronic obstructive pulmonary disease
Interventions 1. Resistance training: The training programme will last 8 weeks and comprise three supervised half-hour lower limb resistance training sessions per week. Training will take place on an isokinetic dynamometer (Cybex II Norm: CSMi, USA)…
Registration date Sep 12, 2009
Target size 120
Secondary IDs MRC ref: G0501985; UHL 10146
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations